If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income (CYN)

Share Price is delayed by 15 minutes
Get Live Data
343.00    4.00 (1.18%)
Bid:
341.00
Ask:
344.00
Spread: 3.00 (0.88%)
Market Cap: £124.20m
CYN Live PriceLast checked at - London Stock Exchange

Intraday CQS Natural Resources Growth & Income Share Chart

Glass Lewis Voting Recommendation

21 Jan 2025 12:00

RNS Number : 1527U
CQS Natural Resources Grwth&Inc PLC
21 January 2025
 

CQS Natural Resources Growth and Income PLC

LEI: 549300ES8CNIK2CQR054

21 January 2025

 

Proxy adviser recommends shareholders vote AGAINST Saba's Requisitioned Resolutions

The Board of CQS Natural Resources Growth and Income PLC (the "Company") notes the publication of a voting recommendation from independent proxy adviser, Glass Lewis, in relation to the Company's forthcoming general meeting to be held at 11 a.m. on 4 February 2025 (the "General Meeting").

Glass Lewis recommends that shareholders in the Company vote AGAINST the resolutions proposed by Saba Capital Management, L.P. ("Saba") for consideration at the General Meeting to remove the current Directors and to appoint Saba nominees in their place (the "Requisitioned Resolutions").

This is in line with the unanimous recommendation of the Company's Board, which continues to urge shareholders to VOTE AGAINST the proposed Requisitioned Resolutions for the reasons set out in the Circular posted to shareholders on 7 January 2025, and available on the Company's website at https://cynprotectyourinvestment.com/.

 

Christopher Casey, Chair of CQS Natural Resources Growth and Income PLC, commented:

"The Board welcomes the recommendation from Glass Lewis for shareholders to vote against the resolutions proposed by Saba at the upcoming General Meeting. Such proxy adviser recommendation underscores our view that Saba's proposals are without merit, introduce new and significant risk to your investment and are not in the best interests of ALL shareholders.

It is vital that shareholders vote at the General Meeting on 4 February and vote AGAINST Saba's Requisitioned Resolutions."

 

General Meeting and How to Vote

The General Meeting to vote on the Requisitioned Resolutions will be held on 4 February 2025 at 11 a.m. at the offices of Dentons UK and Middle East LLP at One Fleet Place, London, EC4M 7RA.

To be valid, proxy appointments must be completed in accordance with the instructions accompanying it and transmitted so received by the Registrar as soon as possible and, in any event, by no later than 11 a.m. on 31 January 2025.

Investors who hold their shares through an investment platform provider or nominee are encouraged to contact their investment platform provider or nominee as soon as possible to arrange for VOTES AGAINST each of the Requisitioned Resolutions to be lodged on their behalf. Please note: customers of online share ownership platforms may have voting deadlines as early as 23 January.

Further information on how to vote through platforms can be found at the following link: https://www.theaic.co.uk/how-to-vote-your-shares.

 

 

For further information, please contact:

CQS Natural Resources Growth and Income PLC

Christopher Casey, Chairman

cnr@tavistock.co.uk

(c/o Tavistock Communications)

Cavendish, Corporate Broker

Robert Peel, Andrew Worne, Tunga Chigovanyika

+44 20 7908 6000

Frostrow Capital LLP, Company Secretary

Eleanor Cranmer

+44 20 3008 4613

cosec@frostrow.com

Tavistock, Public Relations

Jos Simson, Gareth Tredway, Tara Vivian-Neal

+44 20 7920 3150

cnr@tavistock.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAFFFASSSEFA
Date   Source Headline
26th Nov 20257:00 amRNSMonthly Fact Sheet as at 31 October 2025
25th Nov 202511:49 amRNSNet Asset Value(s)
25th Nov 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
24th Nov 202512:45 pmRNSNet Asset Value(s)
21st Nov 20253:39 pmRNSNet Asset Value(s)
20th Nov 202512:49 pmRNSNet Asset Value(s)
19th Nov 202512:56 pmRNSNet Asset Value(s)
18th Nov 202512:36 pmRNSNet Asset Value(s)
17th Nov 202512:07 pmRNSNet Asset Value(s)
14th Nov 20251:50 pmRNSNet Asset Value(s)
13th Nov 20254:02 pmRNSNet Asset Value(s)
12th Nov 20251:03 pmRNSNet Asset Value(s)
11th Nov 202512:39 pmRNSNet Asset Value(s)
10th Nov 20252:06 pmRNSNet Asset Value(s)
7th Nov 20251:40 pmRNSNet Asset Value(s)
6th Nov 202512:11 pmRNSNet Asset Value(s)
5th Nov 202511:52 amRNSNet Asset Value(s)
4th Nov 20251:02 pmRNSNet Asset Value(s)
3rd Nov 20251:30 pmRNSNet Asset Value(s)
3rd Nov 20259:47 amRNSTotal Voting Rights
31st Oct 20254:59 pmRNSDirector/PDMR Shareholding
31st Oct 20253:07 pmRNSNet Asset Value(s)
31st Oct 20252:40 pmRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSShare Buyback Policy
30th Oct 20253:02 pmRNSNet Asset Value(s)
29th Oct 202512:57 pmRNSNet Asset Value(s)
28th Oct 20256:20 pmRNSTransaction in Own Shares
28th Oct 20251:39 pmRNSNet Asset Value(s)
28th Oct 20257:00 amRNSAnnual Financial Report - year ended 30 June 2025
27th Oct 20251:29 pmRNSNet Asset Value(s)
24th Oct 20252:19 pmRNSNet Asset Value(s)
23rd Oct 202512:35 pmRNSNet Asset Value(s)
22nd Oct 20253:07 pmRNSMonthly Fact Sheet as at 30 September 2025
22nd Oct 20251:44 pmRNSNet Asset Value(s)
21st Oct 20251:26 pmRNSNet Asset Value(s)
20th Oct 202512:59 pmRNSNet Asset Value(s)
17th Oct 20252:30 pmRNSNet Asset Value(s)
16th Oct 20253:12 pmRNSNet Asset Value(s)
15th Oct 20252:00 pmRNSNet Asset Value(s)
15th Oct 20251:31 pmRNSDividend Declaration
14th Oct 202512:49 pmRNSNet Asset Value(s)
13th Oct 202512:47 pmRNSNet Asset Value(s)
10th Oct 20252:11 pmRNSNet Asset Value(s)
9th Oct 20252:25 pmRNSNet Asset Value(s)
8th Oct 20255:23 pmRNSSale of Shares from Treasury
8th Oct 20251:43 pmRNSHolding(s) in Company
8th Oct 20251:05 pmRNSNet Asset Value(s)
7th Oct 20254:52 pmRNSHolding(s) in Company
7th Oct 20251:02 pmRNSNet Asset Value(s)
6th Oct 20251:44 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.